Mirtazapine is known to produce auditory hallucination, a auditory effect. Auditory hallucination is the perception of sounds that have no external source — hearing music, voices, environmental noises, or abstract sonic phenomena that exist entirely within the mind. These range from faint, ambiguous whispers at the edge of perception to fully formed, complex musical compositions or conversational speech that can feel completely real and externally sourced.
From a first-person perspective, auditory hallucinations manifest as sounds that feel genuinely external — as though they originate from somewhere in the physical environment — despite having no corresponding source. One may hear faint music playing from another room, indistinct conversational murmuring, environmental sounds like running water or wind, or entirely novel sonic phenomena such as buzzing, chiming, or crystalline tones. At higher intensities, full musical compositions may be perceived with remarkable complexity and fidelity, sometimes in genres or styles the listener has never heard before. Voices may speak coherent sentences, sometimes addressing the user directly, though insight is usually maintained that these are drug-induced.
At threshold levels, auditory hallucinations present as vague, ambiguous sounds — one might question whether a faint sound was real or imagined. At light to moderate intensities, the hallucinations become more distinct: identifiable snippets of music, recognizable whispered words, or phantom environmental sounds like doorbells or phone notifications. At strong doses, fully formed auditory experiences emerge — entire songs with lyrics, complex conversations, or rich environmental soundscapes that are indistinguishable from reality until one actively questions their origin. At overwhelming levels, the hallucinated audio can completely dominate the perceptual field, making it difficult to distinguish real from imagined sound.
Musical hallucinations involve hearing melodies, harmonies, or complete compositions, often novel and not drawn from memory.Verbal hallucinations consist of hearing words or sentences — these may be fragments, gibberish, or coherent speech.Environmental hallucinations replicate familiar ambient sounds (rain, traffic, appliances).Abstract sonic hallucinations produce sounds without clear real-world analogues — geometric buzzing, fractal tones, or sounds that seem to have visual or spatial properties. Auditory hallucinations can beopen-eye (perceived as external) orclosed-eye (perceived as internal, mind's-ear phenomena).
Auditory hallucinations arise from spontaneous activation of auditory cortical areas in the absence of corresponding external stimuli. Serotonergic psychedelics facilitate this through 5-HT2A agonism, which increases spontaneous neural firing in auditory association cortex and disrupts the brain's ability to distinguish internally generated signals from external input. Dissociatives produce auditory hallucinations through NMDA antagonism, which impairs sensory gating mechanisms and can lead to disinhibited firing in temporal lobe auditory regions. Deliriants such as diphenhydramine produce particularly vivid and realistic auditory hallucinations through muscarinic acetylcholine receptor antagonism, which profoundly disrupts the neurotransmitter systems involved in reality testing.
Auditory hallucinations occur across many substance classes but with qualitatively different characters. Psychedelics (LSD, psilocybin, DMT) tend to produce musical and abstract auditory hallucinations, often pleasant and complex.Dissociatives (ketamine, DXM, PCP) can generate immersive sonic environments, particularly during dissociative holes.Deliriants (diphenhydramine, datura) produce the most realistic and often disturbing auditory hallucinations — convincing phantom conversations and environmental sounds that are difficult to distinguish from reality.Cannabis at high doses, particularly edibles, can produce mild auditory hallucinations.Stimulant psychosis from prolonged use of amphetamines or cocaine can generate persecutory auditory hallucinations.
While psychedelic auditory hallucinations are generally benign and often enjoyable, deliriant-induced auditory hallucinations deserve serious caution — they can be indistinguishable from reality and may provoke dangerous behavioral responses. Stimulant-induced auditory hallucinations (especially persecutory voices) are a sign of psychosis and indicate a medical emergency requiring cessation of use and professional help. Individuals with a personal or family history of schizophrenia or psychotic disorders should exercise extreme caution with any substance that produces auditory hallucinations, as these effects may trigger or exacerbate underlying conditions. If hallucinated voices become commanding or frightening, this is a sign to seek immediate support.
Auditory hallucination can manifest at varying intensities depending on the dose of Mirtazapine and individual sensitivity. The following levels describe the typical progression of this effect.
Vague, ambiguous sounds at the edge of perception — faint whispers, phantom notification sounds, or barely audible music that one cannot be sure is real.
Identifiable sounds with no source — distinct musical snippets, recognizable words or phrases, phantom environmental sounds like a ringing phone.
Clear and detailed auditory hallucinations — full melodies, conversational fragments, or rich environmental soundscapes; one can usually still distinguish them from reality.
Complex, vivid auditory experiences — entire songs with lyrics, coherent conversations, or immersive sonic environments that are difficult to distinguish from real sounds.
Complete auditory hallucination dominance — the hallucinated soundscape is indistinguishable from reality; real and imagined sounds merge into a single perceptual stream.
Mirtazapine inhibits presynaptic serotonin (5-HT)-2 and alpha-2 adrenergic auto- and hetero-receptors, thereby increasing serotonergic and noradrenergic neurotransmission. The increased amount of 5-HT released interacts with postsynaptic 5-HT1 receptors, which may be relevant to the antidepressant effects of the drug. The affinity of mirtazapine for central alpha-2 adrenoreceptors is 10 times higher than for peripheral receptors, resulting in fewer peripheral effects related to increased blood pressure. Mirtazapine is an antagonist at postsynaptic 5-HT2A, 5-HT2C, and 5-HT3 receptors. The blockade of these receptors may result in a lower incidence of certain adverse effects (e.g., anxiety, insomnia, nausea) than occurs with antidepressants that do not antagonize these receptors. Mirtazapine significantly antagonizes histamine H1 receptors at low doses, and this activity is associated with sedation and appetite stimulation. Higher doses have a greater effect on norepinephrine release relative to antihistamine effects, which may offset the sedative potential and appetite stimulation observed at low doses. Mirtazapine has muscarinic antagonist properties, which may be associated with xerostomia, constipation, and other anticholinergic effects. Orthostatic hypotension is the result of the peripheral alpha-1 adrenergic antagonism of the drug. Mirtazapine does not have clinically significant receptor affinity for dopamine, 5-HT1A, or 5-HT1B, and has no effects on the central reuptake of either norepinephrine or serotonin.:
Mirtazapine has also been found to modulate the κ3 opioid receptor, supporting the claim that mirtazapine causes pain relief and adds to the sedative and hallucinogenic effects of mirtazapine. This even may explain mirtazapine's withdrawal/discontinuation effects as well as its promotion of diuresis and a possible increase in food intake (usually resulting in weight gain).
It should be noted that although some of these effects are observed in those who take mirtazapine recreationally (or one off dosing) most neurophysiological effects are observed in those with on-going use (15, 30 and 45 mg daily prescribed for depression, etc) due to a maintained level of mirtazapine in the body.
The oral bioavailability of mirtazapine is about 50%. It is found mostly bound to plasma proteins, about 85%. It is metabolized primarily in the liver by demethylation and hydroxylation via cytochrome P450 enzymes, CYP1A2, CYP2D6, CYP3A4. and about 15% is eliminated in feces.
Although mirtazapine exhibits almost exclusively psychedelic effects, the hallucinations that accompany it do have distinctively deliriant-like effects. For example, they are often delirious in their believability and rarely comprised of condensed visual geometry. Instead they tend to be solid and extremely realistic in appearance.
The mental processes, thought patterns and general head space experienced during a high dose mirtazapine experience is one that is typically described to be completely devoid of insight. In contrast to many other substances with hallucinogenic properties, it produces no introspection, personal problem solving or creativity enhancing effects; for this reason it is generally reported that mirtazapine holds no therapeutic potential when used as a hallucinogen.
Mirtazapine is not known to cause brain damage, and has extremely low toxicity relative to dose. Similar to other psychedelic drugs, there are relatively few physical side effects associated with mirtazapine exposure. Various studies have shown that in reasonable doses in a careful context, it presents no negative cognitive, psychiatric or toxic physical consequences of any sort. -not habit-forming when used as a hallucinogen and the desire to use it can actually decrease with use. It is most often self-regulating.almost immediately after ingestion. After that,37 days to be back at baseline (in the absence of further consumption).
Mirtazapine is considered to be relatively safe in the event of an overdose, although it is considered slightly more toxic in overdose than most of the SSRIs (except citalopram). Unlike the TCAs, mirtazapine showed no significant cardiovascular adverse effects at 7 to 22 times the maximum recommended dose. Case reports of overdose with as much as 30 to 50 times the standard dose described the drug as relatively nontoxic, compared to TCAs.
Twelve reported fatalities have been attributed to mirtazapine overdose. The fatal toxicity index (deaths per million prescriptions) for mirtazapine is 3.1 (95% CI: 0.1 to 17.2). This is similar to that observed with SSRIs.
It is strongly recommended that one use harm reduction practices when using this substance. -Antidepressants** - Different types of antidepressants can cause adverse effects as well as possible serotonin syndrome when mixed.
Mirtazapine is legally approved for medical purposes worldwide. However, it is illegal to sell and possess in most countries without a prescription.
Switzerland: Mirtazapine is listed as a "Abgabekategorie B" pharmaceutical, which generally requires a prescription.
Turkey: Mirtazapine is classed as anti-depressant so it is prescription only drug but the law is often unenforced.
United Kingdom:** Mirtazapine is a licensed prescription-only medicine (POM) in the United Kingdom. It is not a criminal offence to possess this medicine without a valid prescription. This medicine can legally be obtained with a valid prescription or through legal import of the medicine for personal use as outlined in Section 13 of the Medicines Act 1968.
United States:** Mirtazapine is not a controlled substance in the United States; however, it is classified as RX only and requires a prescription.
Responsible use
Hallucinogen
Psychedelic
Deliriant
Mirtazapine (Wikipedia)
Mirtazapine (Erowid Vault)
Mirtazapine (Isomer Design)
Mirtazapine (Drugs.com)
Discussion
Mirtazapine, broken down and described (Disregard Everything I Say)
Mirtazapine can be administered via oral. The route of administration can influence both the onset and intensity of auditory hallucination.
The intensity of auditory hallucination depends heavily on the dose of Mirtazapine. Effects like auditory hallucination are typically reported at common to strong doses. Below is the full dosage chart for Mirtazapine.
Warning
Realistic auditory hallucinations, especially from deliriants or stimulant psychosis, can be indistinguishable from reality and may prompt dangerous behavior. Hearing commanding or persecutory voices is a sign of acute psychosis requiring immediate medical attention. Individuals with a history of psychotic disorders should avoid substances that produce this effect.
Yes. Auditory hallucination is a documented auditory effect of Mirtazapine. Auditory hallucination is the perception of sounds that have no external source — hearing music, voices, environmental noises, or abstract sonic phenomena that exist entirely within the mind. These range from faint, ambiguous whispers at the edge of perception to fully formed, complex musical compositions or conversational speech that can feel completely real and externally sourced.
Effects like auditory hallucination are typically reported at common doses and above. A common oral dose of Mirtazapine is 130–190 mg.
Other substances documented to produce auditory hallucination include Diphenhydramine, Datura, Dextromethorphan, Methamphetamine, Ibogaine, and 35 more.